Literature DB >> 1191966

Megaloblastic erythropoiesis and macrocytosis in patients on anticonvulsants.

S N Wickramasinghe, G Williams, J Saunders, J H Durston.   

Abstract

The results of deoxyuridine suppression tests on the bone marrow cells of 14 patients on anticonvulsant drugs, 11 of whom had evidence of megaloblastic erythropoiesis, indicated that the megaloblastic changes and macrocytosis encountered in treated epileptics are often not caused either by folate deficiency or by drug-induced impairment of the 5, 10-methylenetetrahydrofolate-dependent methylation of deoxyuridylate to thymidylate. A folate-related abnormality in the methylation of deoxyuridylate was found in only two of the 11 patients with megaloblastic erythropoiesis.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1191966      PMCID: PMC1674794          DOI: 10.1136/bmj.4.5989.136

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  10 in total

1.  Letter: deoxyuridine suppression test.

Authors:  S N Wickramasinghe; J E Saunders
Journal:  Br Med J       Date:  1975-04-12

2.  Megaloblastic anaemia occurring during primidone therapy.

Authors:  R H GIRDWOOD; J A LENMAN
Journal:  Br Med J       Date:  1956-01-21

3.  Macrocytosis and macrocytic anaemia caused by anticonvulsant drugs.

Authors:  C F HAWKINS; M J MEYNELL
Journal:  Q J Med       Date:  1958-01

4.  Serum folic-acid and vitamin-B12 levels in anticonvulsant therapy.

Authors:  J S Malpas; G H Spray; L J Witts
Journal:  Br Med J       Date:  1966-04-16

5.  Mechanism of folate deficiency in patients receiving phenytoin.

Authors:  A V Hoffbrand; T F Necheles
Journal:  Lancet       Date:  1968-09-07       Impact factor: 79.321

6.  Impairment of intestinal deconjugation of dietary folate. A possible explanation of megaloblastic anaemia associated with phenytoin therapy.

Authors:  I H Rosenberg; H A Godwin; R R Streiff; W B Castle
Journal:  Lancet       Date:  1968-09-07       Impact factor: 79.321

7.  Effects of phenytoin on folic-acid conjugases in man.

Authors:  C M Baugh; C L Krumdieck
Journal:  Lancet       Date:  1969-09-06       Impact factor: 79.321

8.  The dU suppression test using 125 I-UdR to define biochemical megaloblastosis.

Authors:  V Herbert; G Tisman; L Brenner
Journal:  Br J Haematol       Date:  1973-06       Impact factor: 6.998

9.  Folic acid and anticonvulsive drugs.

Authors:  O N Jensen; O V Olesen
Journal:  Arch Neurol       Date:  1969-08

10.  Macrocytosis in patients on anticonvulsant drugs.

Authors:  J A Child; B Z Khattak; J P Knowles
Journal:  Br J Haematol       Date:  1969-05       Impact factor: 6.998

  10 in total
  1 in total

1.  Midazolam and thiopental for the treatment of refractory status epilepticus: a retrospective comparison of efficacy and safety.

Authors:  Flavio Bellante; Benjamin Legros; Chantal Depondt; Jacques Créteur; Fabio Silvio Taccone; Nicolas Gaspard
Journal:  J Neurol       Date:  2016-02-25       Impact factor: 4.849

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.